AIM: Regional chemotherapy using hepatic artery catheters is a good method of treating patients with colorectal cancer liver metastases. We investigated the survival of patients with liver metastases from colorectal cancer using 5-fluorouracil (5-FU) and mitomycin C Cthrough implantable hepatic arterial infusion port. METHODS: Seventy-five patients with inoperable liver metastases from colorectal cancer were included between March, 1992 and November, 2001. We placed implantable hepatic arterial catheter (HAC) port by laparotomy. 5-FU, 1 000 mg / m2/d continuous infusion for five days every four weeks, was delivered in the hepatic arterial catheter through the port. Mitomyci
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
Intra-arterial chemotherapy in patients with liver metastases from colorectal cancer has some limita...
Abstract Background The high complication rates of surgically implanted port catheter systems (SIPCS...
The aim was to investigate whether intra-arterial infusion of chemotherapy improves response to trea...
Background: Only 5-10% of colorectal cancer patients (pts) with liver metastases are eligible for su...
Median survival of untreated patients with LM from CC ranges from 3 to 12 months (m) after diagnosis...
Abstract BACKGROUND: The hypothesis was tested that systemic chemotherapy might contribute to improv...
Stefano Bacchetti, Enricomaria Pasqual, Elena Crozzolo, Alessandra Pellarin, Pier Paolo CagolDepartm...
AIM To evaluate the efficiency and safety of hepatic artery infusion chemotherapy (HAIC) using ral...
Background: Hepatic intra-arterial chemotherapy (HIAC) leads to a higher response rate than systemic...
This focuses on review one of the methods of locoregional treatment \u96 intraarterial hepatic infus...
Background: Despite the progress made in the treatment of metastatic colorectal cancer (CRC), the re...
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
Twenty-five patients with colorectal liver metastases had a subcutaneous portal connection with a pe...
Background: Both hepatic arterial infusion (HAI) of chemotherapy and cetuximab (CET) have interestin...
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
Intra-arterial chemotherapy in patients with liver metastases from colorectal cancer has some limita...
Abstract Background The high complication rates of surgically implanted port catheter systems (SIPCS...
The aim was to investigate whether intra-arterial infusion of chemotherapy improves response to trea...
Background: Only 5-10% of colorectal cancer patients (pts) with liver metastases are eligible for su...
Median survival of untreated patients with LM from CC ranges from 3 to 12 months (m) after diagnosis...
Abstract BACKGROUND: The hypothesis was tested that systemic chemotherapy might contribute to improv...
Stefano Bacchetti, Enricomaria Pasqual, Elena Crozzolo, Alessandra Pellarin, Pier Paolo CagolDepartm...
AIM To evaluate the efficiency and safety of hepatic artery infusion chemotherapy (HAIC) using ral...
Background: Hepatic intra-arterial chemotherapy (HIAC) leads to a higher response rate than systemic...
This focuses on review one of the methods of locoregional treatment \u96 intraarterial hepatic infus...
Background: Despite the progress made in the treatment of metastatic colorectal cancer (CRC), the re...
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
Twenty-five patients with colorectal liver metastases had a subcutaneous portal connection with a pe...
Background: Both hepatic arterial infusion (HAI) of chemotherapy and cetuximab (CET) have interestin...
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
Intra-arterial chemotherapy in patients with liver metastases from colorectal cancer has some limita...
Abstract Background The high complication rates of surgically implanted port catheter systems (SIPCS...